Advanced Research Peptide
Dual Incretin Signaling Research System
GLP-2 (TZ) is a synthetic dual incretin research peptide studied for
GLP-1 and GIP receptor pathway interaction across
metabolic, endocrine, glucose-regulation, and coordinated incretin signaling models.
🧬 Dual Incretin
GLP-1 and GIP pathway research
⚡ Metabolic Focus
Energy balance and glucose models
📊 Endocrine Models
Integrated incretin pathway studies
🔬 Research Grade
Dual-agonist pathway investigation
3rd Party Tested
USA Made
COA Available
High Demand
Only 15 left in stock
Designed for advanced incretin pathway research
Premium dual-pathway peptide with broad metabolic, endocrine, and coordinated receptor signaling relevance.
Research Peptide Price
$165.00
Flexible checkout available
or 4 payments with Klarna
⚠️ For research use only. Not for human or veterinary use.
Product Description
Dual Incretin Agonist Research Peptide (GLP-1 / GIP)
🧪
3rd Party
Tested
Tested
🇺🇸
Made in
USA
USA
📄
COA
Available
Available
GLP-2 (TZ) is a synthetic peptide analog developed for laboratory research examining dual incretin receptor signaling through the glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) pathways. It is supplied exclusively for non-clinical investigation into integrated metabolic and endocrine signaling mechanisms.
Key Research Areas
🧬
Dual-receptor pathway modeling focusing on GLP-1R and GIPR signaling synergy
⚡
Metabolic research models evaluating glucose regulation and energy balance pathways
📊
Incretin-mediated endocrine signaling and pathway cross-talk studies
🔬
Exploratory combination research strategies involving incretin-pathway agents
This peptide is commonly utilized in advanced metabolic research exploring multi-pathway incretin signaling and coordinated endocrine regulation within controlled laboratory settings.
Intended Use
📦 Format: Lyophilized powder (20mg)
⚠️ Use: For laboratory research use only. Not for human or veterinary use.
⚠️ Use: For laboratory research use only. Not for human or veterinary use.
Why Researchers Choose This Compound
🔗
Dual incretin pathway coverage supports research into coordinated GLP-1 and GIP receptor signaling rather than single-pathway models alone.
🧪
Broad metabolic and endocrine relevance makes it useful for glucose-regulation, incretin cross-talk, and energy-balance investigations.
📈
Strong multi-pathway research utility offers a focused framework for studying integrated receptor activity and coordinated endocrine pathway interaction.
Product Notes
✅ Research category: Metabolic and incretin signaling
✅ Study context: Laboratory and non-clinical research models
✅ Compound focus: GLP-1 / GIP receptor interaction and coordinated endocrine pathway signaling
